Downregulation of PP2A is associated with AD pathology, as it leads to Tau hyperphosphorylation, enhanced Aβ levels, increased neurodegeneration, and impaired spatial memory in rodents (Martin et al. 2013; Wang et al. 2015). The gene discussed is MAPT; the disease is Alzheimer disease.